RYTM
NASDAQ · Biotechnology
Rhythm Pharmaceuticals Inc
$84.62
+2.03 (+2.46%)
Performance
1D
—
1W
—
1M
—
3M
-23.07%
6M
-15.92%
1Y
+55.84%
YTD
-19.42%
Open$82.60
Previous Close$82.59
Day High$84.85
Day Low$80.99
52W High$122.20
52W Low$45.91
Volume—
Avg Volume926.2K
Market Cap6.25B
P/E Ratio—
EPS$-3.03
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$105.86
Below
SMA 200
$92.90
Below
RSI (14)
49.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+19.5% upside
Current
$84.62
$84.62
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 195.00M | 975.71M | 873.25M |
| Net Income | -201,972,161 | -22,144,056 | -23,253,892 |
| Profit Margin | -103.6% | -2.3% | -2.7% |
| EBITDA | -194,652,974 | -26,213,634 | -24,112,007 |
| Free Cash Flow | — | -20,824,615 | -25,629,049 |
| Rev Growth | +100.2% | -2.7% | +8.2% |
| Debt/Equity | 0.40 | 0.40 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |